Offer - Urjas Oil for just ₹ 1 X
Rozucor F 5 Tablet is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Rozucor F 5 Tablet have also been mentioned below.
The right dosage of Rozucor F 5 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Rozucor F 5 Tablet also has some side effects, the most common being Nausea or vomiting, Headache, Constipation. While these are the most often observed Rozucor F 5 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Rozucor F 5 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Rozucor F 5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Rozucor F 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Rozucor F 5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes are examples of such conditions.
Besides this, Rozucor F 5 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Rozucor F 5 Tablet is not safe while driving, and is is not addictive in nature.
Rozucor F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rozucor F 5 Tablet safe for pregnant women?
Rozucor F can have harmful effects in pregnant women. If you experience any discomfort after using Rozucor F, then discontinue the use and take your doctor's advice.
Is the use of Rozucor F 5 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Rozucor F. If you see any side effects, stop taking Rozucor F immediately and talk to your doctor. Take Rozucor F again, only after your doctor's advice.
What is the effect of Rozucor F 5 Tablet on the Kidneys?
Very few cases of side effects of Rozucor F on kidney have been reported.
What is the effect of Rozucor F 5 Tablet on the Liver?
Side effects of Rozucor F rarely affect the liver.
What is the effect of Rozucor F 5 Tablet on the Heart?
Rozucor F may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Rozucor F 5 Tablet unless your doctor advises you to do so -
Is this Rozucor F 5 Tablet habit forming or addictive?
No, there is no any evidence that Rozucor F 5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rozucor F 5 Tablet, you should not drive or work on any heavy machine, as Rozucor F 5 Tablet can make you drowsy.
Is it safe?
Yes, but consume Rozucor F 5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Rozucor F 5 Tablet for mental disorders.
Interaction between Food and Rozucor F 5 Tablet
There is no information on the effects of taking Rozucor F 5 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Rozucor F 5 Tablet
Due to lack of research, there is no information about the side effects of taking Rozucor F 5 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650